Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant gain of 144.32% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 98.48%. Over the past 30 days, the price of BMRA has fallen by 133.65%. And in the last five days, it has surged by 123.47%.
Biomerica Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $1.35 on 02/23/24 and the lowest value was $0.24 on 08/05/24.
52-week price history of BMRA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Biomerica Inc’s current trading price is -45.69% away from its 52-week high, while its distance from the 52-week low is 203.60%. The stock’s price range during this period has varied between$0.24 and $1.35. The Biomerica Inc’s shares, which operate in the Healthcare, saw a trading volume of around 334.16 million for the day, a figure considerably higher than their average daily volume of 0.94 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Biomerica Inc (BMRA) has experienced a quarterly rise of 128.34% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 13.45M and boasts a workforce of 64 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3424, with a change in price of +0.2850. Similarly, Biomerica Inc recorded 4,076,649 in trading volume during the last 100 days, posting a change of +65.65%.
BMRA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BMRA stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.05.
BMRA Stock Stochastic Average
As of today, Biomerica Inc’s raw stochastic average for the last 50 days stands at 45.91%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 45.91%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 50.07% and 48.85%, respectively.
